EMN29 study – opportunity & questions

The EMN29 study with Selinexor is ongoing.

If you are a participating site and wish to know more about this study and treatment, you can:

• Visit the following website: https://www.myeloma-europe.org/trials/emn29/
• Contact the trial manager: silvia.villa@emn.org

 

In addition, Prof. Katja Weisel – Principal Investigator of the study – will join the ASH 2023 conference in San Diego, 9-12 December 2023.

Do not miss this opportunity to ask any questions!